Chronic myeloid leukemia (CML), is one of the myeloproliferative disorders with a characteristic cytogenetic abnormality resulting in BCR-ABL fusion gene. Imatinib Mesylate an effective agent for treating patients all stages CML. According to annual Iraqi cancer registry 2019, total number chronic was 338. The percentage and incidence rates were 0.94% 0.86%, respectively, higher rate males than...
